NASDAQ:BTCY Biotricity (BTCY) Stock Price, News & Analysis → Why Big Pharma is Investing Billions in This Biotech (From Behind the Markets) (Ad) Free BTCY Stock Alerts $1.28 -0.02 (-1.54%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$1.22▼$1.3350-Day Range$0.92▼$1.6352-Week Range$0.70▼$4.45Volume131,660 shsAverage Volume115,547 shsMarket Capitalization$12.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Biotricity alerts: Email Address Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About Biotricity Stock (NASDAQ:BTCY)Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Read More BTCY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BTCY Stock News HeadlinesApril 19, 2024 | finanznachrichten.deBiotricity, Inc.: Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 ClinicsApril 17, 2024 | investing.comBiotricity pilots cardiac tech at major hospital networkApril 27, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?April 16, 2024 | finanznachrichten.deBiotricity, Inc.: Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital NetworkMarch 28, 2024 | finanznachrichten.deLOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TVMarch 2, 2024 | finance.yahoo.comBiotricity, Inc. (BTCY) Interactive Stock Chart - Yahoo FinanceFebruary 29, 2024 | finanznachrichten.deBiotricity, Inc.: Biotricity Receives Health Canada Clearance for BiotresFebruary 22, 2024 | finance.yahoo.comBiotricity, Inc. (NASDAQ:BTCY) Q3 2024 Earnings Call TranscriptApril 27, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?February 21, 2024 | benzinga.comBiotricity Stock (NASDAQ:BTCY) Dividends: History, Yield and DatesFebruary 20, 2024 | finance.yahoo.comBiotricity Inc. (BTCY) Reports Q3 Loss, Misses Revenue EstimatesFebruary 20, 2024 | finanznachrichten.deBiotricity, Inc.: Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21stNovember 16, 2023 | finance.yahoo.comBiotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call TranscriptNovember 14, 2023 | benzinga.comBiotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024November 10, 2023 | finance.yahoo.comBiotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14thOctober 3, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Announces Patient Filing for Cutting-Edge Biotres DeviceSeptember 13, 2023 | finance.yahoo.comBiotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge InnovationsAugust 30, 2023 | finanznachrichten.deBiotricity, Inc.: Biotricity Achieves $14 Million Revenue Run Rate in August 2023August 30, 2023 | finance.yahoo.comBiotricity Achieves $14 Million Revenue Run Rate in August 2023See More Headlines Receive BTCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2024Today4/27/2024Next Earnings (Estimated)7/04/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:BTCY CUSIPN/A CIK1630113 Webwww.biotricity.com Phone(800) 590-4155FaxN/AEmployees55Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.3899) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,660,000.00 Net Margins-125.43% Pretax Margin-125.43% Return on EquityN/A Return on Assets-233.67% Debt Debt-to-Equity RatioN/A Current Ratio0.21 Quick Ratio0.10 Sales & Book Value Annual Sales$9.64 million Price / Sales1.25 Cash FlowN/A Price / Cash FlowN/A Book Value($2.27) per share Price / Book-0.56Miscellaneous Outstanding Shares9,420,000Free Float7,493,000Market Cap$12.06 million OptionableOptionable Beta1.51 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Waqaas Al-Siddiq Ph.D. (Age 39)Founder, President, CEO & Chairman Comp: $732kMr. S. John Ayanoglou (Age 57)Chief Financial Officer Comp: $305.75kMr. Andy WongVice President of OperationsDr. George N. NikopoulosDirector of Business DevelopmentMr. Matt ZabelVice President of Sales & StrategyMr. Amir AliChief Development OfficerMore ExecutivesKey CompetitorsPetVivoNASDAQ:PETVMicrobot MedicalNASDAQ:MBOTGlucoTrackNASDAQ:GCTKNEXGELNASDAQ:NXGLT2 BiosystemsNASDAQ:TTOOView All CompetitorsInstitutional OwnershipAdvisor Resource CouncilBought 79,070 shares on 4/19/2024Ownership: 0.839%Simplex Trading LLCSold 2,300 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions BTCY Stock Analysis - Frequently Asked Questions Should I buy or sell Biotricity stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" BTCY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BTCY, but not buy additional shares or sell existing shares. View BTCY analyst ratings or view top-rated stocks. How have BTCY shares performed in 2024? Biotricity's stock was trading at $1.15 at the beginning of 2024. Since then, BTCY stock has increased by 11.3% and is now trading at $1.28. View the best growth stocks for 2024 here. Are investors shorting Biotricity? Biotricity saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 443,400 shares, an increase of 23.7% from the March 31st total of 358,400 shares. Based on an average daily volume of 96,900 shares, the short-interest ratio is currently 4.6 days. Approximately 5.6% of the shares of the stock are sold short. View Biotricity's Short Interest. When is Biotricity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024. View our BTCY earnings forecast. How were Biotricity's earnings last quarter? Biotricity, Inc. (NASDAQ:BTCY) issued its quarterly earnings results on Tuesday, February, 20th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.41) by $0.07. The firm had revenue of $2.97 million for the quarter, compared to the consensus estimate of $3 million. When did Biotricity IPO? Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO. Who are Biotricity's major shareholders? Biotricity's stock is owned by a variety of institutional and retail investors. Top institutional investors include Advisor Resource Council (0.84%). How do I buy shares of Biotricity? Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BTCY) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace4 Cryptos BETTER than BitcoinTrue Market InsidersThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
